News from Cytos A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 08, 2014, 16:55 ET

Cyto Wave Technologies Announces Exclusive Letter of Intent With UC San Francisco

Cyto Wave Technologies Inc. (the "Company") (OTCQB: CWAV) announced today that it entered into an exclusive letter of intent ("LOI") with the...

Feb 13, 2014, 01:00 ET

Cytos Biotechnology Announces Full Year 2013 Financial Results

Cytos Biotechnology Ltd (SIX:CYTN) today presented its full year 2013 financial results. Full year consolidated financial figures 2013: Balance...

Jan 29, 2014, 01:00 ET

Singapore's First Influenza Vaccines Demonstrates Favorable Immunogenicity and Tolerability in Clinical Testing

Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that their influenza...

Dec 30, 2013, 08:30 ET

Extraordinary Shareholders' Meeting of Cytos Biotechnology Ltd: Shareholders Approve all Resolutions

Cytos Biotechnology Ltd (SIX:CYTN) today announced that its shareholders have approved all resolutions at the Extraordinary Shareholders'...

Dec 04, 2013, 01:00 ET

Dr. Yamo Deniz to Join Cytos Biotechnology's Board of Directors

Cytos Biotechnology Ltd (SIX:CYTN) ("Cytos" or the "Company") today announced that Dr. Yamo Deniz is proposed to join Cytos' Board of Directors....

Nov 18, 2013, 01:00 ET

Cytos Biotechnology Ltd: Rights Offering Oversubscribed - CHF 24.3 Million Raised

Cytos Biotechnology Ltd (SIX:CYTN) ("Cytos" or the "Company") today announced the completion of a financing transaction that raised a total of...

Nov 04, 2013, 07:28 ET

Extraordinary Shareholders' Meeting of Cytos Biotechnology Ltd: Shareholders Approve All Resolutions

Cytos Biotechnology Ltd (SIX:CYTN) today announced that its shareholders have approved all resolutions at the Extraordinary Shareholders' Meeting...

Oct 31, 2013, 02:00 ET

Cytos Biotechnology Ltd Reports Third Quarter 2013 Financial Results and Recent Developments

- Completion of patient enrolment in the ongoing Phase 2b clinical trial with CYT003 - Investor syndicate will pay Cytos CHF 6.625...

Oct 21, 2013, 01:46 ET

Cytos Biotechnology Ltd Announces the Completion of Patient Enrolment in the On-going Phase 2b Study of CYT003 for the Treatment of Allergic Asthma

Cytos Biotechnology Ltd (SIX:CYTN) ("Cytos" or the "Company") today announced that patient enrolment has been completed in the on-going phase 2b...

Oct 17, 2013, 13:36 ET

Cytos Biotechnology Ltd to Host Investor and Analyst R&D Day in New York City

Cytos Biotechnology Ltd (SIX:CYTN) will host an Investor and Analyst R&D Day for institutional investors and research analysts on Wednesday,...

Sep 09, 2013, 01:00 ET

Cytos Biotechnology Presents Additional Results From Phase 2a Study of CYT003 for the Treatment of Allergic Asthma

Cytos Biotechnology Ltd (SIX:CYTN) today announced additional results of the phase 2a clinical trial with CYT003, a first-in-class immune...

Aug 06, 2013, 01:00 ET

Cytos Biotechnology Ltd Reports Second Quarter 2013 Financial Results and Recent Developments

- Global Phase 2b clinical trial with CYT003 progressing as planned - Development team for CYT003 strengthened - A*Star and Cytos...

Jun 28, 2013, 13:00 ET

Annual Shareholders' Meeting of Cytos Biotechnology Ltd: Shareholders Approve All Resolutions

Cytos Biotechnology Ltd (SIX:CYTN) today announced that its shareholders have approved all resolutions at the Annual Shareholders' Meeting...

Jun 06, 2013, 01:00 ET

Cytos Invites to the Annual Shareholders' Meeting 2013

Cytos Biotechnology Ltd ("Cytos") today announced that the Annual Shareholders' Meeting 2013 will take place on Friday, 28 June 2013, at 10 a.m....

May 17, 2013, 01:00 ET

A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing

Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy...

Apr 25, 2013, 01:00 ET

Cytos Biotechnology Ltd Reports First Quarter 2013 Financial Results and Recent Development

 -    Phase 2b clinical trial of CYT003 in allergic asthma on-going as...

Mar 13, 2013, 02:05 ET

The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study Results With Cytos Biotechnology's CYT003 for the Treatment of Allergic Asthma

Cytos Biotechnology Ltd (SIX:CYTN) today announced the publication of the results from its phase 2a clinical trial with CYT003-QbG10 (CYT003), a...

Mar 12, 2013, 02:05 ET

Cytos Biotechnology Strengthens Management Team

Cytos Biotechnology Ltd (SIX:CYTN) today announced the appointment of Matthias Alder as Executive Vice President for Corporate Development and...

Feb 14, 2013, 01:00 ET

Cytos Biotechnology Announces Full Year 2012 Financial Results

Cytos Biotechnology Ltd (SIX:CYTN) today presented its full year 2012 financial results. Full year consolidated financial figures 2012: Balance...

Feb 04, 2013, 01:45 ET

Cytos VLP Platform is Basis for Phase 1 Clinical Trial with Anti-IgE Vaccine

Cytos Biotechnology Ltd (SIX:CYTN) has been informed by Pfizer Inc. that the first patient has been dosed in a Phase 1 clinical trial with an...